Liver shunt study targets muscle wasting in cirrhosis
NCT ID NCT06794853
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at why a procedure called TIPS (which helps blood flow in the liver) might also improve muscle loss (sarcopenia) in people with advanced liver disease. Researchers will measure a protein called FGF21 in the blood and track changes in muscle mass and strength over one year. The goal is to understand the mechanism, not to test a new treatment. About 132 adults with cirrhosis who need TIPS will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, 430022, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can nerve changes explain Age-Related muscle loss?
- Muscle loss in aging: can diet and exercise turn back the clock?
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- Muscle-Saving supplement may shield seniors from Weight-Loss drug side effect
- Can surgery for stomach or esophageal cancer cloud the mind?